Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3580]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Trastuzumab emtansine improves overall survival versus treatment of physician's...
Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium
Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cance ( Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium )
17 Dec 2015
Editor's choice for December 2015
Prof Gordon McVie - ecancer Editor
Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )
16 Dec 2015
Denosumab improves disease-free survival for postmenopausal patients with HR...
Prof Michael Gnant - Medical University of Vienna, Vienna, Austria
Denosumab improves disease-free survival for postmenopausal patients with HR-positive breast cancer ( Prof Michael Gnant - Medical University of Vienna, Vienna, Austria )
9 Dec 2015
Long-term outcomes after blinatumomab treatment for ALL
Dr Nicola Gökbuget - University of Frankfurt, Frankfurt, Germany
Long-term outcomes after blinatumomab treatment for ALL ( Dr Nicola Gökbuget - University of Frankfurt, Frankfurt, Germany )
7 Dec 2015
Chemoprevention in breast cancer and possible vaccine for prostate cancer
Dr Leslie Ford - National Cancer Institute, Rockville, USA
Chemoprevention in breast cancer and possible vaccine for prostate cancer ( Dr Leslie Ford - National Cancer Institute, Rockville, USA )
7 Dec 2015
Response to rituximab induction is a predictive biomarker in post-transplant...
Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy
Response to rituximab induction is a predictive biomarker in post-transplant lymphoproliferative disorder ( Prof Corrado Tarella - Istituto Europeo di Oncologia, Milano, Italy )
7 Dec 2015
ASH 2015: Highlights in mantle cell lymphoma
Prof Simon Rule and Prof Steven Le Gouill
ASH 2015: Highlights in mantle cell lymphoma ( Prof Simon Rule and Prof Steven Le Gouill )
7 Dec 2015
Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic...
Prof Giovanni Martinelli - University of Bologna, Bologna, Italy
Blinatumomab has promising effect on hard-to-treat, rare acute lymphoblastic leukaemia subtype ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )
6 Dec 2015
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia
Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia ( Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France )
6 Dec 2015
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia
Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano...
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia ( Dr Alessandra Tedeschi - Azienda Ospedaliera Niguarda Cà Granda Milano, Milano, Italy )
6 Dec 2015
Idelalisib combination therapy in relapsed or treatment-resistant CLL better...
Dr Andrew Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA
Idelalisib combination therapy in relapsed or treatment-resistant CLL better than standard regimen ( Dr Andrew Zelenetz - Memorial Sloan Kettering Cancer Center, New York, USA )
6 Dec 2015
ASH 2015: Novel combination approaches for multiple myeloma
Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios...
ASH 2015: Novel combination approaches for multiple myeloma ( Prof Marivi Mateos, Prof Sagar Lonial, Dr Torben Plesner, Prof Meletios Dimopoulos )
6 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation